Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational ...

The FDA has granted fast ... from both influenza and COVID-19, according to a Dec. 16 AJMC report. These vaccine candidates combine the flu vaccine with the Novavax COVID-19 vaccine, offering ...

Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

Sanofi has announced that its two combination vaccine ... COVID-19 vaccine, while the second consists of Sanofi’s recombinant protein-based trivalent flu vaccine Flublok and the Novavax vaccine. The ...

US FDA lifts clinical hold on Novavax's combo COVID-flu shot Healthcare & Pharmaceuticalscategory· November 11, 2024 Moderna reported a surprise third-quarter profit on Thursday, driven by cost ...

The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s currently authorized COVID ... after the FDA lifted the clinical hold on ...